Reckitt Benckiser Group (LON:RKT – Free Report) had its price objective boosted by JPMorgan Chase & Co. from GBX 5,800 to GBX 6,500 in a research note published on Tuesday morning, MarketBeat reports. The brokerage currently has an overweight rating on the stock.
Several other equities analysts also recently issued reports on the stock. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a GBX 5,400 price objective on shares of Reckitt Benckiser Group in a research note on Thursday, July 30th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 5,900 target price on shares of Reckitt Benckiser Group in a report on Wednesday, July 29th. Berenberg Bank upped their target price on Reckitt Benckiser Group from GBX 5,179 to GBX 5,352 and gave the company a “hold” rating in a research report on Wednesday, August 5th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and set a GBX 6,200 price target on shares of Reckitt Benckiser Group in a research report on Wednesday, July 29th. Four analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of GBX 6,178.86.
View Our Latest Analysis on RKT
Reckitt Benckiser Group Stock Down 0.4%
Reckitt Benckiser Group (LON:RKT – Get Free Report) last issued its earnings results on Wednesday, July 29th. The company reported GBX 101.40 earnings per share (EPS) for the quarter. Reckitt Benckiser Group had a net margin of 21.09% and a return on equity of 42.87%. Research analysts expect that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current fiscal year.
Insider Buying and Selling
In other news, insider Deborah Waterhouse acquired 152 shares of the stock in a transaction that occurred on Wednesday, August 26th. The shares were purchased at an average cost of GBX 5,189 per share, for a total transaction of £7,887.28. Also, insider Deepak Nath acquired 257 shares of the company’s stock in a transaction on Tuesday, June 23rd. The stock was purchased at an average cost of GBX 4,650 per share, for a total transaction of £11,950.50. Insiders bought 1,032 shares of company stock valued at $21,636,131 in the last ninety days. Company insiders own 0.45% of the company’s stock.
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
